Uppsala Monitoring Centre
Uppsala Monitoring Centre[edit | edit source]
The Uppsala Monitoring Centre (UMC) is an independent, non-profit foundation and a centre for international service and scientific research in the field of pharmacovigilance. It is located in Uppsala, Sweden. UMC was established in 1978 to support the World Health Organization's (WHO) Programme for International Drug Monitoring.
History[edit | edit source]
The Uppsala Monitoring Centre was founded in 1978 as a result of a WHO initiative to create a global system for monitoring the safety of medicines. The centre was established in Uppsala, Sweden, due to the country's strong tradition in pharmaceutical research and development. Since its inception, UMC has played a crucial role in collecting and analyzing data on adverse drug reactions (ADRs) from around the world.
Functions[edit | edit source]
UMC's primary function is to manage the WHO Programme for International Drug Monitoring, which involves collecting and analyzing reports of adverse drug reactions from member countries. The centre maintains the VigiBase, the largest global database of ADRs, which is used to identify potential safety issues with medicines. UMC also develops tools and methodologies for signal detection and risk assessment in pharmacovigilance.
Research and Development[edit | edit source]
UMC is involved in various research projects aimed at improving the safety of medicines. The centre collaborates with academic institutions, regulatory authorities, and the pharmaceutical industry to advance the science of pharmacovigilance. UMC also provides training and education to healthcare professionals and regulatory staff worldwide.
Global Impact[edit | edit source]
The work of UMC has had a significant impact on global public health by improving the safety of medicines. The centre's efforts have led to the identification of numerous safety signals, resulting in changes to drug labels, withdrawal of unsafe medicines, and the development of safer therapeutic alternatives.
Related Pages[edit | edit source]
References[edit | edit source]
Facade logo of Uppsala Monitoring Centre
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
